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Abstract
Background/Aims: Existing research on the health of transgender young adults focuses largely 
on gender-related care with little attention to important preventive healthcare services such as 
well-visits, vaccination and screening.
Methods: We analyzed data from a national sample of transgender young adults in the United 
States who were 18–26 years of age and completed an online survey during Fall 2013 (n=34). 
Most respondents were 22–26 years old (59%) and non-Hispanic White (68%). We calculated 
descriptive statistics (i.e., frequencies and percentages) to describe transgender young adults use of 
preventive healthcare services, with particular attention to vaccination against human 
papillomavirus (HPV) and sexual health services. We also examined the acceptability of home-
based self-testing for sexually-transmitted infections (STIs), which could be a novel strategy for 
increasing screening among this population.
Results: Only 35% of respondents reported either receiving a routine check-up (past year) or 
initiating the HPV vaccination series (≥1 dose). Among unvaccinated respondents, the most 
commonly reported reasons for not getting HPV vaccine were: not being sexually active (32%); 
having only 1 sexual partner (23%); and being unaware of the vaccine (23%). Fewer than half of 
respondents had been tested for STIs (47%) but most (71%) were willing to use an STI self-test at 
home.
Discussion: Findings suggest that the healthcare needs of transgender young adults are not 
being adequately addressed. Efforts to increase providers’ capacity to effectively and appropriately 
Correspondence to: Annie-Laurie McRee.
(Corresponding author). 
Declaration of conflict of interest
The authors have no conflict of interest to declare.
HHS Public Access
Author manuscript
Int J Transgend. Author manuscript; available in PMC 2019 May 25.
Published in final edited form as:
Int J Transgend. 2018 ; 19(4): 417–423. doi:10.1080/15532739.2018.1470593.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
serve transgender young adults—such as a wider variety of exam, preventive services, and testing 
options (e.g., self-collected samples)—are needed.
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Transgender and gender non-conforming people experience a broad range of health 
disparities compared to their cisgender (i.e., sex assigned at birth and gender identity match) 
peers, ranging from mental health problems, such as anxiety and depression, to physical 
health problems, including sexually transmitted infections (STIs) and obesity (Bockting, 
Miner, Swinburne Romine, Hamilton, & Coleman, 2013; Bouman et al., 2017; Clark et al., 
2014; Eisenberg et al., 2017; Feldman, Romine, & Bockting, 2014; Millet, Longworth, & 
Arcelus, 2017; Veale, Watson, Peter, & Saewyc, 2017). Healthy People 2020 calls for 
research to understand factors predicting health in this understudied population (U.S. 
Department of Health and Human Services). Much of the existing research in this area has 
focused on transgender adults, with specific attention to gender-related care. Comparatively 
less research has included transgender adolescents and young adults, who require the same 
age-appropriate preventive care as their cisgender counterparts, including well-care visits, 
screening, and immunizations (Society for Adolescent Health and Medicine, 2013), yet 
experience different health risks and barriers to care. Young adulthood is a key time for 
transitions in healthcare. During the period from 18–26 years, youth generally transition 
from a parent/guardian’s health insurance coverage to independent coverage (Park, Scott, 
Adams, Brindis, & Irwin, 2014). This transition from adolescent- to adult-focused care may 
also coincide with the selection of a new healthcare provider, allowing an opportunity to 
access more gender-competent healthcare providers if that was not an option previously. 
Unfortunately, data suggest this population may have lower healthcare utilization than 
cisgender populations with perceived discrimination by healthcare providers being a primary 
cause (Clark, Veale, Townsend, Frohard-Dourlent, & Saewyc, 2018; Macapagal, Bhatia, & 
Greene, 2016; Poteat, German, & Kerrigan, 2013). Hesitancy to disclose gender identity 
and/or sexual orientation can be a key barrier to care, and this information may be 
particularly relevant to clinical decision making when caring for sexually active young 
adults (Macapagal et al., 2016). Lack of disclosue may be due may be due to patient and/or 
provider attitudes and behavior (e.g., providers not asking about identity, or patient belief 
that identity is not relevant for healthcare) (Rossman, Salamanca, & Macapagal, 2017) or 
clinic materials (e.g., paperwork and electronic records that do not include gender identity) 
(Cahill & Makadon, 2014) and could contribute to negative healthcare experiences for 
young adults who identify as transgender (Macapagal et al., 2016). Furthermore, 
considerations specific to this population around genital examination including the roles of 
patient gender dysphoria, limited provider training, and genital changes due to hormone 
therapy that may make genital exams more uncomfortable, may also be barriers to accessing 
important preventive services, such as Papanicolaou (Pap) and STI tests (where indicated) 
(Felman & Goldberg, 2006; Peitzmeier, Reisner, Harigopal, & Potter, 2014) In sum, 
underutilization of preventive care by transgender young adults is a problem that necessitates 
creative solutions. The present study examines use of preventive healthcare services among 
transgender young adults, with particular attention to HPV vaccination and services related 
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to sexual health including acceptability of at-home STI testing, which could be a novel 
alternative strategy for increasing preventive screening among this population.
Methods
Study Design
We analyzed data from an online survey conducted in October and November of 2013 with a 
national sample of young adults (Harris Interactive, 2013b). Respondents were recruited 
through the Harris Interactive Online Panel, a voluntary research panel which includes 
respondents throughout the United States (U.S.) and is similar to the U.S. population on 
several demographic characteristics (Harris Interactive, 2013a; McRee, Katz, Paskett, & 
Reiter, 2014; Reiter, McRee, Katz, & Paskett, 2015). In exchange for completing surveys, 
panel members receive points that can later be redeemed for rewards. Individuals were 
eligible to participate in our survey if they were aged 18–26; lived in the U.S.; and identified 
themselves as lesbian, gay, bisexual or transgender. The study was approved by the 
Institutional Review Board at The Ohio State University. Of 2,014 eligible individuals, 1,005 
provided informed consent and completed the survey. The present analysis uses data from 
respondents who self-identified as transgender on the survey company’s demographic 
screener (n=34) which used a single item to assess LGBT identity (heterosexual or straight, 
lesbian, gay, bisexual, transgender). As this approach confounds gender identity and sexual 
orientation, we added follow-up survey questions assessing sex assigned at birth (male, 
female) and current gender identity (male, female, transmale/transman, transfemale/
tranwoman, genderqueer, other) among those respondents who identified as transgender on 
the screener (Sausa, Sevelius, Keatley, Iñiguez, & Reyes, 2009). Half of respondents in our 
analytic sample (50%, n=17) identified as a trans man or trans male (Table 1). Most 
respondents were: between the ages of 22–26 years (59%), non-Hispanic White (68%), had 
annual household incomes less than $50,000 (US), and lived in suburban (44%) or urban 
(35%) areas.
Measures and analyses
We developed survey items based on existing items in the literature. Questions about general 
healthcare access and experiences included respondents’ health insurance status and receipt 
of a routine checkup in the past year (Table 2). We assessed whether respondents had 
disclosed their sexual orientation or gender identity to their healthcare provider and their 
perception of ever having been discriminated against by a provider because of their sexual 
orientation or gender identity (Rainbow Health Initiative, 2013). The survey also assessed 
whether respondents had ever received any shots of human papillomavirus (HPV) vaccine 
(Brewer et al., 2011), a vaccine which protects against a common STI that can cause 
multiple types of cancer (Petrosky et al., 2015). Unvaccinated respondents then indicated the 
main reason why they had not yet gotten any HPV vaccine shots and their intentions to get 
vaccinated in the next year (Reiter, Brewer, McRee, Gilbert, & Smith, 2010; Reiter, McRee, 
Katz, & Paskett, 2015).
Sexual heath and healthcare questions assessed: respondents’: sexual experience; history of 
HIV testing; whether respondents had ever had a test for STIs (“such as gonorrhea, 
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chlamydia or syphilis, not including HIV”); and whether they had ever been told by a 
provider that they had HIV, HPV, genital warts, or another STI. After providing a brief 
description of a hypothetical self-test for STIs that would involve collecting a urine 
specimen or using a swab to get a genital specimen that is then mailed to a doctor for testing 
(McRee, Esber, & Reiter, 2015; Thompson et al., 2015), the survey assessed respondents’ 
willingness to perform a self-test for STIs and asked what concerns they would have about 
using a home-based test for STIs (check all that apply).
We calculated descriptive statistics (i.e., frequencies and percentages) for all variables using 
Stata/IC version 13 (StataCorp, College Station, TX).
Results
Healthcare access and experiences
Most respondents had health insurance, either through a parent’s plan (65%) or themselves 
(21%), though, notably, 15% indicated having none (Table 2). Only 35% reported having 
received a routine check-up in the past year. Two thirds of respondents (65%) indicated that 
they had disclosed their sexual orientation or gender identity to their healthcare provider, and 
about a quarter (27%) felt a provider had discriminated against them because of their sexual 
orientation or gender identity.
HPV vaccination.—About one-third (35%, n=12) of respondents reported having received 
any shots of HPV vaccine. Eight (67%) of those who had initiated HPV vaccination (24% of 
total sample) had completed the 3-dose series. Among unvaccinated respondents, the most 
common main reasons for not getting HPV vaccine were: not being sexually active (32%); 
having only 1 sexual partner who does not have HPV (23%); and never having heard of the 
vaccine (23%). When asked about their intentions to get HPV vaccine in the next year, half 
(50%) of unvaccinated respondents were undecided.
Sexual healthcare.—Overall, 63% of respondents reported ever having vaginal, anal or 
oral sex. Fewer than half of all respondents had ever had a test for STIs (47%) or HIV (42%) 
and few reported ever having received an STI diagnosis from a healthcare provider (9%). 
Most respondents (71%) were willing to use an STI self-test at home. The most commonly 
reported concerns about using an STI self-test were that the test might not be accurate (68%) 
and that they might do the test incorrectly (65%). Fewer respondents reported preferring to 
see a doctor for a test (41%), not wanting to send the test through the mail (21%), or concern 
that the test might hurt (15%) or be embarrassing (12%).
Discussion
Findings from this national sample suggest that the regular, preventive healthcare needs of 
transgender and gender non-conforming young adults are not being adequately addressed. 
While young adults generally have lower levels of health services use than other age groups, 
a substantially lower proportion of young adults who identified as transgender—just 1 in 3
—reported receiving a routine check-up in the past year, compared to 49%−58% among 
general populations of young adults (Adams, Park, & Irwin, 2015). Other research also finds 
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a similar pattern of differences among adolescent populations (Rider et al., 2018). Many 
young adults in our sample reported either not disclosing their gender identity to a provider, 
or perceiving discrimination by a provider; these, coupled with stressors, such as fear of 
stigma (Hendricks & Testa, 2012), could play a role in low preventive healthcare services 
use among this population. Further, young adults receiving gender-affirming medical 
interventions (e.g., hormone therapy) may be less likely to seek routine preventive care as 
they are already under the care of a specialist who may not provide such services. However, 
receipt of preventive care provides critical opportunities screening and counseling about 
behavioral health risks that are the key source of morbidity and mortality among this age 
group (Eisenberg et al., 2017; Park et al., 2015; Ozer, Urquhart, Brindis, Park, & Irwin, 
2012). This is one of the first studies, to our knowledge, to assess HPV vaccination among 
transgender youth (Gorbach et al., 2017). Only one-third of young adults in this sample had 
received at least one dose of HPV vaccine, a proportion that is similar to vaccination 
coverage among a national sample of female young adults in the general population during 
the same time period but higher than among males (37% and 6%, respectively; Williams et 
al., 2015). Respondents’ reasons for not yet getting vaccinated point to information gaps that 
can also be addressed in future interventions. As the vast majority of unvaccinated 
respondents either intended to get vaccinated against HPV or were undecided, it is 
particularly important to provide strong, quality recommendations targeted to young adults 
as these are a strong and consistent predictor of vaccination (Gilkey et al., 2016). Given 
lower levels of services used among transgender young adults, it becomes especially 
important for healthcare providers to take advantage of every clinical opportunity, including 
visits for acute care, to promote routine screening and immunization. Further offering HPV 
and other recommended vaccines in alternative settings, such as pharmacies, could also 
increase access for populations—such as transgender young adults—who do not regularly 
access healthcare services in a clinic setting (Shah, Gilkey, Pepper, Gottlieb, & Brewer, 
2014).
Many young adults in this study had never been tested for STIs. There are likely a variety of 
reasons for this, some stemming from gender identity (e.g., unwillingness to access services 
due to anticipated discrimination) and others more general. However, we found that most 
were willing to use an STI self-test at home, similar to previous findings among other 
populations (McRee et al., 2015), as well as recent research which finds high levels of 
acceptability for self-sampling for HPV (Seay et al., 2017). These results are encouraging 
given the low level of STI testing in the sample, and they further suggest that self-testing 
could be a viable way to screen transgender young adults, providing a promising alternative 
to clinician-collected samples among a population with documented barriers to accessing 
care.
Study strengths include a national sample of transgender young adults and inclusion of a 
range of measures of health and healthcare services. However, caution is needed when 
interpreting findings due to the small sample size, a common issue in research with small, 
hard-to-reach populations. Given our sample size, we were unable to examine differences in 
healthcare services identified in previous research, such as those based on race and ethnicity 
(Seelman, Young, Tesene, Alvarez-Hernandez, & Kattari, 2017; White Hughto, Murchison, 
Clark, Pachankis, & Reisner, 2016). The inclusion of gender identity measures on national 
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population-based surveys, such as the National Health Interview Survey, would allow for 
further probing of important differences in care, and is critical for monitoring trends in 
health status and health care utilization over time. Additional limitations include a cross-
sectional design, a modest response rate, and a single item of LGBT identity used as a 
survey screener. Our measures of sexual behavior and healthcare services were based on 
self-report. However, previous research supports the reliability of young adults’ reports of 
both sexual behavior (Sieving et al., 2001) and HPV vaccination (which results in a net bias 
of only 2% compared to medical records (Rolnick et al., 2013). Anonymous, web-based 
administration of our survey may increase reliability of sensitive items such as sexual 
behavior. The survey did not assess respondents’ specific sexual practices, mental or 
physical health problems, or whether respondents received any gender-affirming medical 
interventions. Finally, our findings regarding HPV vaccination intent and willingness to use 
an STI self-test may overstate actual practice as intentions do not always translate into health 
behavior (Ajzen, 2011).
Conclusion
Many transgender young adults are not receiving preventive healthcare services, including 
those related to HPV vaccination and sexual health. Given the documented barriers to care, 
novel approaches are needed to address this issue. For example, our findings suggest that use 
of home-based self-testing could improve STI screening rates and offer an alternative 
strategy to augment traditional clinic-based testing. A wider variety of exam, preventive 
services, and testing solutions, coupled with recommended training and education for 
providers in offering gender-competent care (Society for Adolescent Health and Medicine, 
2013), could support health professionals in meeting transgender young adults’ health needs 
in patient-centered ways.
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Table 1
Sample demographic characteristics
n (%)
Demographic characteristics
Gender identitya
    Male, trans male or trans man 17 (50.0)
    Female, trans female or trans woman 10 (29.4)
    Genderqueer 7 (20.6)
Sex assigned at birth
    Female 23 (67.6)
    Male 11 (32.4)
Age
    18–21 14 (41.2)
    22–26 20 (58.8)
Race / Ethnicity
    Non-Hispanic White 23 (67.7)
    Non-Hispanic Black 2 (5.9)
    Hispanic 5 (14.7)
    Other race/ethnicity 4 (11.8)
Education
    Less than college 9 (26.5)
    Some college 13 (38.2)
    College degree or more 12 (35.3)
Relationship status
    Never married, divorced, widowed, separated 23 (67.7)
    Living with a partner, civil union, married 11 (32.4)
Employment status
    Currently employed 18 (52.9)
    Not employed 11 (32.4)
    Student 5 (14.7)
Annual household income
    <$50,000 21 (61.8)
    ≥$50,000 9 (26.5)
    Not reported 4 (11.8)
Urbanicity
    Rural 7 (20.6)
    Suburban 15 (44.1)
    Urban 12 (35.3)
Region of residence
    East 11 (32.4)
    Midwest 5 (14.7)
    South 9 (26.5)
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n (%)
    West 9 (26.5)
Note. Percentages may not sum to 100 due to rounding.
aAmong respondents who identified as transgender
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Table 2
Health and healthcare services among transgender young adults
n (%)
General healthcare services and experiences
Insurance status
    No health insurance 5 (14.7)
    Insures self (work, school, etc.) 7 (20.6)
    Insured through parent’s plan 12 (64.7)
Usual place for health care
    Private doctor’s office 19 (55.9)
    Community clinic or school/university clinic 10 (29.4)
    None or emergency room 5 (14.7)
Had a routine check-up in past year
    No 22 (65.7)
    Yes 12 (35.3)
Disclosed sexual orientation or gender identity to a healthcare provider
    No 12 (35.3)
    Somewhat 4 (11.8)
    Yes 18 (52.9)
Perceived discrimination by healthcare provider
    No 20 (58.8)
    Yes 9 (26.5)
    Don’t know 5 (14.7)
HPV vaccination
Received any shots of HPV vaccine
    No 22 (64.7)
    Yes 12 (35.3)
Intent to get vaccinated in next yeara
    No 4 (18.2)
    Undecided 11 (50.0)
    Yes 7 (31.8)
Sexual healthcare
Ever had sexb
    No 13 (38.2)
    Yes 21 (61.7)
Ever had a test for HIV
    No/don’t know 20 (58.8)
    Yes 14 (41.2)
Last time had an STI test (other than HIV)
    Never/don’t know 19 (52.9)
    1 year ago or less 13 (38.2)
    Over 1 year ago 3 (8.8)
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n (%)
Ever told by provider had…
    HIV 1 (2.9)
    HPV infection 0 --
    Genital warts 1 (2.9)
    Other STI (e.g., gonorrhea, Chlamydia, herpes) 1 (2.9)
Willingness to us a self-test for STIs
    Not willing 3 (5.9)
    Not sure 8 (23.5)
    Willing 24 (70.6)
Note. Percentages may not sum to 100 due to rounding.
HIV=human immunodeficiency virus; HPV=human papillomavirus; STI=sexually transmitted infection
aAmong unvaccinated respondents (n=22)
b
Defined as “vaginal, anal, or oral sex”
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